Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gammaplex in children and adolescents with primary immunodeficiency diseases
2011-005679-18Phase 4
- Sponsor
- Bio Products Laboratory
- Start
- Dec 2011
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polyvalent human immunoglobulin in Immunogenetic disorder, sponsored by Bio Products Laboratory. Primary endpoint: Serious acute bacterial infections per subject per year.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
Immunogenetic disorder
Beyond the preview
Go deeper on 2011-005679-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005679-18.